A comparison of first-line treatment with gemcitabine plus docetaxel versus gemcitabine plus vinorelbine in women with metastatic breast cancer

Authors
Category Primary study
JournalInternational Journal of Gynecological Cancer
Year 2013
This article has no abstract
Epistemonikos ID: 5fbff60180f528079be325ff78f68391b665e03d
First added on: Feb 05, 2025